In Italy elective bariatric and metabolic surgery was cancelled on February 21,2020 at the beginning of the so-called phase 1 of the SARS-CoV-2 outbreak. Gradually it was restarted on May 4,2020 at the beginning of the so-called phase 2, when epidemiological data showed containment of the infection. Before the outbreak in eight high-volume bariatric centers 840 patients were surgically treated developing a Covid-19 infection, during phase 1, in only 5 cases (0.6%) without mortality. The post-operative complication rate was similar when compared to the 836 subjects submitted to bariatric surgery the year before. Since the high prevalence of infection in subjects with BMI. 30, it was argued that early intervention on obesity during phase 2 could help to minimize the effects of the disease in the event of a possible reversion to a SARS-CoV-2 outbreak phase 1. At the same time a prospective observational study from July 1 till the WHO declaration of the end of the pandemic has started in the eight high volume centers to monitor the post-operative outcome and its effect on SARS-CoV2 infection. (C) 2020 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Marinari, G.m., Anselmino, M., Tascini, C., Bernante, P., Foletto, M., Gentileschi, P., et al. (2020). Bariatric and metabolic surgery during COVID-19 outbreak phase 2 in Italy: why, when and how to restart. SURGERY FOR OBESITY AND RELATED DISEASES, 16(10), 1614-1618 [10.1016/j.soard.2020.06.025].

Bariatric and metabolic surgery during COVID-19 outbreak phase 2 in Italy: why, when and how to restart

Gentileschi, Paolo;
2020

Abstract

In Italy elective bariatric and metabolic surgery was cancelled on February 21,2020 at the beginning of the so-called phase 1 of the SARS-CoV-2 outbreak. Gradually it was restarted on May 4,2020 at the beginning of the so-called phase 2, when epidemiological data showed containment of the infection. Before the outbreak in eight high-volume bariatric centers 840 patients were surgically treated developing a Covid-19 infection, during phase 1, in only 5 cases (0.6%) without mortality. The post-operative complication rate was similar when compared to the 836 subjects submitted to bariatric surgery the year before. Since the high prevalence of infection in subjects with BMI. 30, it was argued that early intervention on obesity during phase 2 could help to minimize the effects of the disease in the event of a possible reversion to a SARS-CoV-2 outbreak phase 1. At the same time a prospective observational study from July 1 till the WHO declaration of the end of the pandemic has started in the eight high volume centers to monitor the post-operative outcome and its effect on SARS-CoV2 infection. (C) 2020 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.
Pubblicato
Rilevanza internazionale
Recensione
Esperti anonimi
Settore MED/18
English
Bariatric Surgery
COVID-19
Comorbidity
Coronavirus Infections
Disease Transmission, Infectious
Humans
Obesity
Pneumonia, Viral
SARS-CoV-2
Time Factors
Betacoronavirus
Pandemics
Marinari, G.m., Anselmino, M., Tascini, C., Bernante, P., Foletto, M., Gentileschi, P., et al. (2020). Bariatric and metabolic surgery during COVID-19 outbreak phase 2 in Italy: why, when and how to restart. SURGERY FOR OBESITY AND RELATED DISEASES, 16(10), 1614-1618 [10.1016/j.soard.2020.06.025].
Marinari, Gm; Anselmino, M; Tascini, C; Bernante, P; Foletto, M; Gentileschi, P; Morino, M; Olmi, S; Toppino, M; Silecchia, G
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
bariatric.pdf

accesso aperto

Licenza: Non specificato
Dimensione 338.12 kB
Formato Adobe PDF
338.12 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/306480
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 6
social impact